Volume 29, Issue 3
DOI: 10.24205/03276716.2020.932
Study on Clinical Nursing of Nano Albumin Paclitaxel in The Treatment of Advanced Lung Cancer
Abstract
This study aims to observe the clinical efficacy, safety and nursing experience of nano albumin paclitaxel in the treatment of advanced lung cancer. At this moment, 100 patients with advanced lung cancer admitted from January 2019 to December 2019 were selected and given nano albumin paclitaxel 100 mg / m2 single drug regimen or combined regimen to observe adverse reactions and evaluate the efficacy. With the experimental results show nano albumin paclitaxel-based treatment scheme has a certain effect on the treatment of advanced lung cancer regardless of the pathological type and the number of treatment lines. Patients after line therapy were well tolerated. The application of nano albumin paclitaxel in the treatment of advanced malignant tumors should pay attention to observe the changes of the disease and give proper nursing measures, and the patients can tolerate adverse reactions.
Keywords
nano albumin paclitaxel; lung cancer; nursing